- Home
- MTCH vs BIO Comparison
MTCH vs BIO Comparison
Compare MTCH & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTCH
- BIO
- Stock Information
- Founded
- MTCH 1986
- BIO 1952
- Country
- MTCH United States
- BIO United States
- Employees
- MTCH N/A
- BIO N/A
- Industry
- MTCH Computer Software: Programming Data Processing
- BIO Biotechnology: Laboratory Analytical Instruments
- Sector
- MTCH Technology
- BIO Industrials
- Exchange
- MTCH Nasdaq
- BIO Nasdaq
- Market Cap
- MTCH 8.2B
- BIO 9.1B
- IPO Year
- MTCH 2015
- BIO N/A
- Fundamental
- Price
- MTCH $31.69
- BIO $342.01
- Analyst Decision
- MTCH Buy
- BIO Strong Buy
- Analyst Count
- MTCH 20
- BIO 4
- Target Price
- MTCH $37.89
- BIO $414.00
- AVG Volume (30 Days)
- MTCH 4.5M
- BIO 158.1K
- Earning Date
- MTCH 01-28-2025
- BIO 02-13-2025
- Dividend Yield
- MTCH 0.60%
- BIO N/A
- EPS Growth
- MTCH 27.57
- BIO N/A
- EPS
- MTCH 2.24
- BIO N/A
- Revenue
- MTCH $3,485,425,000.00
- BIO $2,580,209,000.00
- Revenue This Year
- MTCH $5.48
- BIO N/A
- Revenue Next Year
- MTCH $1.01
- BIO $2.92
- P/E Ratio
- MTCH $14.12
- BIO N/A
- Revenue Growth
- MTCH 6.12
- BIO N/A
- 52 Week Low
- MTCH $27.66
- BIO $262.12
- 52 Week High
- MTCH $39.91
- BIO $387.99
- Technical
- Relative Strength Index (RSI)
- MTCH 45.35
- BIO 53.78
- Support Level
- MTCH $30.69
- BIO $335.42
- Resistance Level
- MTCH $33.80
- BIO $351.96
- Average True Range (ATR)
- MTCH 0.81
- BIO 9.09
- MACD
- MTCH -0.13
- BIO 2.06
- Stochastic Oscillator
- MTCH 31.75
- BIO 59.23
About MTCH Match Group Inc.
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Hinge, BLK, Chispa, Match.com, OkCupid, PlentyOfFish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.